Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.

Background: We attempted to train and validate a model of deep learning for the preoperative prediction of the response of patients with intermediate-stage hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE).Method: All computed tomography (CT) images were acquired for 5...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 30; no. 1; pp. 413 - 425
Autores principales: Peng, Jie, Kang, Shuai, Ning, Zhengyuan, Deng, Hangxia, Shen, Jingxian, Xu, Yikai, Zhang, Jing, Zhao, Wei, Li, Xinling, Gong, Wuxing, Huang, Jinhua, Liu, Li
Formato: Journal Article
Publicado: Springer Nature Jan2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=140064720&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 140064720
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Jan2020
      vid: 30
      iid: 1
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        140064720
        140064720
        NLM31332558
        10.1007/s00330-019-06318-1
        NLM31332558
        140064720
      ppf: 413
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
      aug:
        au:
          Peng, Jie
          Kang, Shuai
          Ning, Zhengyuan
          Deng, Hangxia
          Shen, Jingxian
          Xu, Yikai
          Zhang, Jing
          Zhao, Wei
          Li, Xinling
          Gong, Wuxing
          Huang, Jinhua
          Liu, Li
        affil: Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, 510515, Guangzhou, China
      sug:
        subj:
          Carcinoma, Hepatocellular
          Chemoembolization, Therapeutic
          Tomography, X-Ray Computed
          Carcinoma, Hepatocellular Therapy
          Liver Neoplasms
          Liver Neoplasms Therapy
          Middle Age
          Female
          Carcinoma, Hepatocellular Pathology
          Retrospective Design
          Male
          Disease Progression
          Liver Neoplasms Pathology
          Scales
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: We attempted to train and validate a model of deep learning for the preoperative prediction of the response of patients with intermediate-stage hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE).Method: All computed tomography (CT) images were acquired for 562 patients from the Nan Fang Hospital (NFH), 89 patients from Zhu Hai Hospital Affiliated with Jinan University (ZHHAJU), and 138 patients from the Sun Yat-sen University Cancer Center (SYUCC). We built a predictive model from the outputs using the transfer learning techniques of a residual convolutional neural network (ResNet50). The prediction accuracy for each patch was revaluated in two independent validation cohorts.Results: In the training set (NFH), the deep learning model had an accuracy of 84.3% and areas under curves (AUCs) of 0.97, 0.96, 0.95, and 0.96 for complete response (CR), partial response (PR), stable disease (SD), and progressive disease (PD), respectively. In the other two validation sets (ZHHAJU and SYUCC), the deep learning model had accuracies of 85.1% and 82.8% for CR, PR, SD, and PD. The ResNet50 model also had high AUCs for predicting the objective response of TACE therapy in patches and patients of three cohorts. Decision curve analysis (DCA) showed that the ResNet50 model had a high net benefit in the two validation cohorts.Conclusion: The deep learning model presented a good performance for predicting the response of TACE therapy and could help clinicians in better screening patients with HCC who can benefit from the interventional treatment.Key Points: • Therapy response of TACE can be predicted by a deep learning model based on CT images. • The probability value from a trained or validation deep learning model showed significant correlation with different therapy responses. • Further improvement is necessary before clinical utilization.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N